Sort
326,823 grants matching “clinical trial”
Development of immunology and immunization strategies that induce broadly pro
$18,720,629Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2016 · AI
ECOG-ACRIN NCORP Research Base
$18,695,221Lynne I. Wagner · Ecog-Acrin Medical Research Foundation · UG1 · FY2024 · CA
LOC-IMPAACT Leadership Group
$18,690,967Sharon A Nachman · Johns Hopkins University · UM1 · FY2018 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$18,661,040Michael David Hughes · Harvard School Of Public Health · UM1 · FY2021 · AI
Clinical & Research Informatics
$18,648,438David Songco · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIH · FY2017 · HD
NINDS Office of the Clinical Director
$18,637,868Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZID · FY2024 · NS
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$18,631,293Michael David Hughes · Harvard School Of Public Health · UM1 · FY2022 · AI
DIAN-TU Primary Prevention Trial
$18,566,145Eric Martin McDade · Washington University · U01 · FY2018 · AG
American College of Radiology Imaging Network
$18,559,159American College Of Radiology · U01 · FY2005 · CA
Laboratory Support Services
$18,536,341Michael L. Polis · National Institute Of Allergy And Infectious Diseases · ZID · FY2009 · AI
DMID CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT
$18,528,537Melynda Holmes · Technical Resources Inc · N01 · FY2014 · AI
Office of Sponsor and Regulatory Oversight
$18,493,892James L. Gulley · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
$18,482,472Karen P Alexander · Duke University · U19 · FY2022 · AG
Canine Immuno-Oncology
$18,408,319Ralph Parchment · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
All of Us Research Program Trans-America Consortium of the HCSRN
$18,393,034Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences · OT2 · FY2023 · OD
Critical Path to Public Private Partnerships
$18,377,119Klaus Romero · Critical Path Institute · U18 · FY2022 · FD
CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older SDMC
$18,322,345Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Regulatory Support Services
$18,316,527Jerome Pierson · National Institute Of Allergy And Infectious Diseases · ZID · FY2018 · AI
Development/production of universal influenza vaccines
$18,309,884Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2018 · AI
ECHO Coordinating Center
$18,172,311Phillip Brian Smith · Duke University · U2C · FY2017 · OD
The Adaptive COVID-19 Treatment Trial (ACTT)
$18,166,213Beth Baseler · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
An Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral Sclerosis
$18,136,504Sabrina Paganoni · Massachusetts General Hospital · UF1 · FY2022 · NS
SOUTHWEST ONCOLOGY GROUP--CCOP RESEARCH BASE
$18,134,974Cancer Therapy And Research Center · U10 · FY2000 · CA
HIV VACCINE TRAILS NETWORK LEADERSHIP GROUP
$18,073,186Fred Hutchinson Cancer Research Center · U01 · FY2001 · AI
CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
$18,042,059Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA